Latham Advises Samsung Medison on Acquisition of Sonio

Latham & Watkins has advised Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, on its agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company. The transaction is subject to approval by the relevant authorities.

Together with Sonio’s world-class AI expertise, Samsung Medison’s leading-edge ultrasound systems will help bring to market breakthrough AI-enhanced workflows and accelerate innovation in patient outcomes and quality of prenatal care.

The Latham team in Paris was led by partner Olivier du Mottay, with Jacek Urban and Eléonore Béthouart. Advice was also provided on healthcare and life sciences matters by partner Eveline Van Keymeulen, with Jeanne Fabre; on employment matters by partner Matthias Rubner, with Léo Theillac; on IP and IT matters by partner Jean-Luc Juhan, with Daniel Martel and Jean Bergeron, and Singapore associate Alex Park; on data privacy matters by partner Myria Saarinen, with Charlotte Guérin; on finance matters by Paris partner Michel Houdayer, with Léa Demulder; and on foreign direct investment matters by partner Charles-Antoine Guelluy, with Christos Ierna.